Ceo
CurrentMATWIN “Maturation & Accelerating Translation With Industry” is a premier French open-innovation platform in oncology and a 100% subsidiary of Unicancer (which gathers the 18 French Comprehensive Cancer Centres).For over 15 years now, the platform has been offering a range of initiatives designed to accelerate innovation in the field (support programs, expertise, coaching, events, etc.). Its action is based on a long-standing partnership with some several international companies keen to… Show more MATWIN “Maturation & Accelerating Translation With Industry” is a premier French open-innovation platform in oncology and a 100% subsidiary of Unicancer (which gathers the 18 French Comprehensive Cancer Centres).For over 15 years now, the platform has been offering a range of initiatives designed to accelerate innovation in the field (support programs, expertise, coaching, events, etc.). Its action is based on a long-standing partnership with some several international companies keen to demonstrate their investment in the fight against cancer, and to develop their watch activity on innovations of interest in the field (Amgen, AstraZeneca, Boehringer Ingelheim, BMS, Exact Sciences, GSK, insitro, MSD, Pfizer, Pierre Fabre, Roche, Sanofi, Takeda). Within the last 15 years, MATWIN has already supported 300+ projects, contributed to the creation of 50 startups, and launched 30+ clinical trials.Our objectives :- identify & select innovative oncology assets & technologies - offer a support to increase their transfer potential- optimize early partnerships for the benefit of patientsMore on : https://matwin.fr/en/home/MATWIN est une plateforme français exclusivement dédiée à l'innovation en oncologie, filiale à 100% d'Unicancer, la fédération qui rassemble les 18 Centres de Lutte Contre le Cancer. Depuis + de 15 ans, la plateforme propose différentes actions visant à accélérer l’innovation dans le domaine (programme accélérateur, expertise, coaching, événements, etc.). Son action s’appuie sur un partenariat historique avec une quinzaine de labos soucieux de marquer leur investissement en oncologie et développer leur activité de veille sur les innovations d’intérêt dans le domaine (Amgen, AstraZeneca, Boehringer Ingelheim, BMS, Exact Sciences, GSK, insitro, MSD, Pfizer, Pierre Fabre, Roche, Sanofi, Takeda). En 15 ans, MATWIN a déjà accompagné +300 projets, contribué à créer 50 startups, à lancer une 30aine d’essais cliniques.Plus d'infos sur : www.matwin.fr Show less